Search Results - "Steklov, Mikhail"
-
1
OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination
Published in EMBO molecular medicine (01-03-2016)“…Activation of the RAS oncogenic pathway, frequently ensuing from mutations in RAS genes, is a common event in human cancer. Recent reports demonstrate that…”
Get full text
Journal Article -
2
Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform
Published in Molecular therapy. Nucleic acids (12-12-2023)“…Genome engineering technologies are powerful tools in cell-based immunotherapy to optimize or fine-tune cell functionalities. However, their use for multiple…”
Get full text
Journal Article -
3
375 Enhanced anti-tumor activity and T-cell fitness of 2nd-generation MAGE-A1 TCR T-cells incorporating distinct CD8 co-receptor designs
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundGeneration of dual CD4/CD8 TCR-T products by redirecting CD4+ T-cells to peptide-MHC class I complexes through incorporation of a CD8 co-receptor…”
Get full text
Journal Article -
4
368 Counteracting TCR-T cell dysfunction in solid tumors through combination of FAS-based switch receptors and CD8-coreceptor
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundThe immunosuppressive tumor microenvironment (TME) impedes solid tumor treatment by adoptive T cell therapies. Tumor-resident cells express multiple…”
Get full text
Journal Article -
5
Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor
Published in Cancer communications (London, England) (01-12-2023)“…[...]those who undergo surgery may experience neurological deficits. [...]the management of schwannomas can be problematic due to their unpredictable growth…”
Get full text
Journal Article -
6
394 High-affinity PRAME TCRs synergize with tailored CD8 co-receptor and switch receptors to generate potential best-in-class PRAME-targeting TCR-T therapy
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundPRAME is a promising target for immunotherapy due to high prevalence and high expression in multiple tumor indications with high unmet medical need…”
Get full text
Journal Article -
7
146 Evolving Mutliplexed shRNA to generate tailored CAR T cell therapy
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundManipulating protein expression to generate cells with a specific desired phenotype is one of the central goals of engineered cell therapy. Short…”
Get full text
Journal Article -
8
Structural basis for cytokinin receptor signaling: an evolutionary approach
Published in Plant cell reports (01-06-2013)“…Cytokinins are ubiquitous plant hormones; their signal is perceived by sensor histidine kinases—cytokinin receptors. This review focuses on recent advances on…”
Get full text
Journal Article -
9
K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins
Published in The EMBO journal (10-06-2024)“…The RAS pathway is among the most frequently activated signaling nodes in cancer. However, the mechanisms that alter RAS activity in human pathologies are not…”
Get full text
Journal Article -
10
Plant membrane assays with cytokinin receptors underpin the unique role of free cytokinin bases as biologically active ligands
Published in Journal of experimental botany (01-04-2015)“…Cytokinin receptors play a key role in cytokinin-dependent processes regulating plant growth, development, and adaptation; therefore, the functional properties…”
Get full text
Journal Article -
11
Single vector multiplexed shRNA provides a non-gene edited strategy to concurrently knockdown the expression of multiple genes in CAR T cells
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 3103 Background: Engineered T cells expressing chimeric antigen receptors (CAR) are now delivering clinically relevant results in patients with…”
Get full text
Journal Article -
12
Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development
Published in Cancer research (Chicago, Ill.) (15-08-2021)“…Meningiomas are the most common benign brain tumors. Mutations of the E3 ubiquitin ligase TRAF7 occur in 25% of meningiomas and commonly cooccur with mutations…”
Get full text
Journal Article -
13
Abstract PR04: A bimodal mechanism of RAS inactivation by monoubiquitination
Published in Molecular cancer research (01-05-2023)“…Abstract The RAS pathway is the most frequently activated signaling node in human cancer. Nevertheless, the mechanisms leading to the hyperactivation of…”
Get full text
Journal Article -
14
The Noonan Syndrome Gene Lztr1 Controls Cardiovascular Function by Regulating Vesicular Trafficking
Published in Circulation research (08-05-2020)“…Noonan syndrome (NS) is one of the most frequent genetic disorders. Bleeding problems are among the most common, yet poorly defined complications associated…”
Get full text
Journal Article -
15
Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells
Published in Molecular biology of the cell (15-03-2020)“…Chromosome segregation during mitosis is antagonistically regulated by the Aurora-B kinase and RepoMan (recruits PP1 onto mitotic chromatin at…”
Get full text
Journal Article -
16
Abstract A14: Mutations in the ubiquitin ligase adaptor LZTR1 drive human disease by dysregulating RAS ubiquitination and signaling
Published in Molecular cancer research (01-05-2020)“…Abstract Genetic evidence explicitly points out a role for LZTR1, an adaptor for cullin 3 (CUL3) ubiquitin ligase complex, in human disease. Mutations in LZTR1…”
Get full text
Journal Article -
17
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
Published in Oncotarget (30-10-2014)“…Inappropriate activation of epidermal growth factor receptor (EGFR) plays a causal role in many cancers including colon cancer. The activation of EGFR by…”
Get full text
Journal Article -
18
OTUB 1 triggers lung cancer development by inhibiting RAS monoubiquitination
Published in EMBO molecular medicine (01-03-2016)“…Activation of the RAS oncogenic pathway, frequently ensuing from mutations in RAS genes, is a common event in human cancer. Recent reports demonstrate that…”
Get full text
Journal Article -
19
Facile Synthesis of 8-Azido-6-Benzylaminopurine
Published in Nucleosides, nucleotides & nucleic acids (01-07-2011)“…Bromination of 6-benzylaminopurine (1) with Br 2 in AcOH in the presence of AcONa afforded 6-benzylamino-8-bromopurine (2) in 59% yield. The position of…”
Get full text
Journal Article